Bruker Co. (NASDAQ:BRKR) Shares Acquired by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. grew its stake in shares of Bruker Co. (NASDAQ:BRKR) by 0.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 467,335 shares of the medical research company’s stock after purchasing an additional 470 shares during the period. Epoch Investment Partners Inc. owned about 0.32% of Bruker worth $29,821,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. TD Asset Management Inc lifted its stake in Bruker by 7.4% during the first quarter. TD Asset Management Inc now owns 1,788,763 shares of the medical research company’s stock valued at $168,036,000 after buying an additional 123,984 shares in the last quarter. Congress Asset Management Co. MA lifted its position in shares of Bruker by 3.5% in the 1st quarter. Congress Asset Management Co. MA now owns 1,414,362 shares of the medical research company’s stock valued at $132,865,000 after acquiring an additional 47,301 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Bruker by 8.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,277,273 shares of the medical research company’s stock worth $81,508,000 after purchasing an additional 101,539 shares during the period. Norges Bank purchased a new position in Bruker during the 4th quarter worth approximately $74,582,000. Finally, Bank of New York Mellon Corp raised its stake in Bruker by 3.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 966,069 shares of the medical research company’s stock valued at $61,645,000 after purchasing an additional 27,870 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on BRKR shares. Citigroup decreased their target price on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, July 10th. Wells Fargo & Company started coverage on Bruker in a research note on Tuesday, August 27th. They set an “overweight” rating and a $78.00 target price on the stock. The Goldman Sachs Group dropped their target price on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, July 9th. Jefferies Financial Group started coverage on shares of Bruker in a report on Monday, June 3rd. They set a “buy” rating and a $85.00 price target for the company. Finally, TD Cowen cut their target price on shares of Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $81.40.

Bruker Stock Performance

Shares of BRKR opened at $67.54 on Monday. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18. Bruker Co. has a 12 month low of $53.79 and a 12 month high of $94.86. The company’s fifty day moving average is $64.56 and its 200-day moving average is $72.64. The firm has a market cap of $9.82 billion, a price-to-earnings ratio of 24.56, a price-to-earnings-growth ratio of 2.31 and a beta of 1.18.

Bruker (NASDAQ:BRKR) last posted its earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, meeting the consensus estimate of $0.52. The company had revenue of $800.70 million for the quarter, compared to analyst estimates of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business’s revenue was up 17.4% compared to the same quarter last year. During the same period last year, the company earned $0.50 earnings per share. Equities analysts expect that Bruker Co. will post 2.61 EPS for the current fiscal year.

Bruker Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Monday, September 2nd were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a yield of 0.30%. Bruker’s payout ratio is currently 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.